Europe Type 1 Diabetes Epidemiology and Patient Flow Analysis - 2017 Description
Fore Pharma
Europe Type 1 Diabetes Epidemiology and Patient Flow Analysis - 2017
Fore Pharma announced the results of its Type 1 Diabetes patients study in a new report ‘Europe Type 1 Diabetes Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Type 1 Diabetes epidemiology, Type 1 Diabetes diagnosed patients, and Type 1 Diabetes treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Type 1 Diabetes derived from epidemiological analysis, percentage of patients diagnosed with Type 1 Diabetes, and percentage of patients treated with a therapy.
The study helps executives estimate Type 1 Diabetes market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Type 1 Diabetes prevalence, Type 1 Diabetes diagnosis rate, and Type 1 Diabetes treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.
Key Features of the Report:
- Type 1 Diabetes Patient Flow
- Type 1 Diabetes Prevalence
- Type 1 Diabetes Diagnosed Patients
- Type 1 Diabetes Treated Patients
